Sur vs Zambia: Previously treated cases tested for RR-/MDR-TB
Sur
62.0%
in 2024
Zambia
100.0%
in 2024
Sur rank
1st
Zambia rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Sur
- Zambia
How they compare
Zambia currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Zambia's figure about 1.6 times Sur's.
The two have swapped places 5 times across 12 shared years of data; in 2008 it was Sur ahead.
Sur ranks 1st and Zambia ranks 1st of 1 regions.
Sur has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sur | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.5% | 6.1% | 15.4% | Sur |
| 2010s | 74.8% | 24.0% | 50.8% | Sur |
| 2020s | 78.4% | 78.4% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Sur or Zambia?
- Zambia, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Sur and Zambia?
- 38.0%, with Zambia ahead.
- How many years of comparable data are there for Sur and Zambia?
- 12 years are reported by both, from 2008 to 2024.
- How do Sur and Zambia rank globally for previously treated cases tested for rr-/mdr-tb?
- Sur ranks 1st and Zambia ranks 1st of 1 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.